AP-III-a4 hydrochloride
CAS No. 2070014-95-6
AP-III-a4 hydrochloride ( ENOblock hydrochloride )
产品货号. M25058 CAS No. 2070014-95-6
AP-III-a4 (ENOblock) 盐酸盐是一种非底物类似物烯醇化酶抑制剂,IC50 为 0.576 uM。 AP-III-a4盐酸盐可用于癌症和糖尿病的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥922 | 有现货 |
|
| 5MG | ¥1729 | 有现货 |
|
| 10MG | ¥2779 | 有现货 |
|
| 25MG | ¥5566 | 有现货 |
|
| 50MG | ¥7859 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥2389 | 有现货 |
|
生物学信息
-
产品名称AP-III-a4 hydrochloride
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述AP-III-a4 (ENOblock) 盐酸盐是一种非底物类似物烯醇化酶抑制剂,IC50 为 0.576 uM。 AP-III-a4盐酸盐可用于癌症和糖尿病的研究。
-
产品描述AP-III-a4 (ENOblock) hydrochloride is a nonsubstrate analogue enolase inhibitor with an IC50 of 0.576 uM. AP-III-a4 hydrochloride can be used for the research of cancer and diabetic.AP-III-a4 (ENOblock) (0-10 μM; 24 h) inhibits HCT116 cell viability in a dose-dependent manner.AP-III-a4 directly binds to enolase and inhibits its activity.AP-III-a4 (0-10 μM; 24 or 48 h) inhibits cancer cell migration and invasion, induces cancer cell apoptosis.AP-III-a4 (10 μM; 24 h) can induce glucose uptake and inhibit phosphoenolpyruvate carboxykinase (PEPCK) expression in hepatocytes and kidney cells.
-
体外实验Cell Viability Assay Cell Line:HCT116 Concentration:1.25, 2.5, 5 and 10 μM Incubation Time:24 h Result:Induced higher levels of HCT116 colon cancer cell death in hypoxic conditions compared to normoxia.Western Blot Analysis Cell Line:HCT116 Concentration:1.25, 2.5, 5 and 10 μM Incubation Time:24 h for AKT, 48 h for Bcl-Xl Result:Bound to enolase in cell lysate and bound to purified enolase. Decreased the expression of AKT and Bcl-Xl, which are negative regulators of apoptosis.Cell Invasion Assay Cell Line:HCT116 Concentration:0.156, 0.312, 0.625, 1.25 and 2.5 μM Incubation Time:24 h Result:Significantly inhibits cancer cell invasion at a treatment concentration of 0.625 μM.Cell Migration Assay Cell Line:HCT116 Concentration:0.625, 1.25 and 2.5 μM Incubation Time:24 h esult:Inhibited cell migration dose-dependently.RT-PCR Cell Line:Huh7 and HEK Concentration:10 μM Incubation Time:24 hResult:Induced glucose uptake and inhibited PEPCK expression.
-
体内实验Animal Model:The zebrafish cancer cell HCT116 xenograft model Dosage:10 μM Administration:96 h Result:Reduced cancer cell dissemination. Inhibited PEPCK expression and induced glucose uptake. Inhibited adipogenesis and foam cell formation.
-
同义词ENOblock hydrochloride
-
通路Apoptosis
-
靶点Apoptosis
-
受体IC50: 0.576 uM (enolase)
-
研究领域——
-
适应症——
化学信息
-
CAS Number2070014-95-6
-
分子量631.18
-
分子式C31H44ClFN8O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : ≥ 53 mg/mL (83.97 mM)
-
SMILES——
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Da-Woon Jung, et al. A Unique Small Molecule Inhibitor of Enolase Clarifies Its Role in Fundamental Biological Processes.ACS Chem. Biol., 2013, 8 (6), pp 1271–1282 [Content Brief]
产品手册
关联产品
-
Geranylgeraniol
香叶基香叶醇是一种类异戊二烯,存在于水果、蔬菜和谷物(包括大米)中。香叶基香叶醇抑制多种肿瘤细胞的生长并诱导其凋亡。香叶基香叶醇可保护单核细胞免受他汀类药物诱导的细胞毒性并抑制分枝杆菌的生长。
-
PDK4-IN-1 hydrochlor...
PDK4-IN-1 盐酸盐是一种蒽醌衍生物,是丙酮酸脱氢酶激酶 4 的有效口服活性抑制剂(PDK4,IC50 值 = 84 nM)。
-
MKC-1
MKC-1 是一种口服生物可利用的小分子双吲哚马来酰亚胺细胞周期抑制剂,具有潜在的抗肿瘤活性。 MKC-1 及其代谢物抑制微管蛋白聚合,阻断有丝分裂纺锤体的形成。
021-51111890
购物车()
sales@molnova.cn

